Skip to content

Author

Johnnie J. Orozco

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

First-In-Human Study of 211At-CD45 Radioimmunotherapy With Nonmyeloablative Conditioning Hematopoietic Cell Transplantation for Adults With Hematologic Malignancies.

211At-CD45 RIT can be incorporated into nonmyeloablative conditioning, with liver toxicity defining activity limits, and evidence of antitumor efficacy supports phase II evaluation.

Phuong T. Vo, R. Walter, T. Gooley et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.